Clinical Trial

Exploring Central Sensitization in Pregnant Women

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 1, 2025 (before its estimated July 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
Pelvic Girdle Pain (PGP) is reported by 50% of pregnant women and up to 11 years after pregnancy, 10% of women have persistent and per definition chronic PGP. Central (nervous system) sensitization that elicits pain hypersensitivity, may be one explanation. The overall aim of this study is to explore features of central sensitization in pregnant women and its predictive ability on physical activity, functioning and health in women with PGP. Measurements of central sensitization will be done on two study groups, pregnant women with PGP and healthy controls. To identify women at risk to develop chronic pain in relation to a common pain experience ie PGP in pregnancy, may help us understand if central sensitization early in life explains why women develop chronic pain.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2022-08-17; most recent amendment 2025-03-31.
Status change: Not Yet Recruiting → Recruiting 2024-09-12
Trial Details
NCT Number NCT05507853
Lead Sponsor Göteborg University
Collaborators: Vastra Gotaland Region
Conditions Pelvic Girdle Pain, Chronic Pain
Enrollment 144 participants
Start Date 2023-08-15
Primary Completion 2025-07-01 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-04-01